RethinkHIV

Smarter Ways to Invest in Ending HIV in Sub-Saharan Africa

Bjørn Lomborg (Copenhagen Business School)

$57.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Cambridge University Press
18 October 2012

HIV & AIDS: social aspects; Health economics; Medicine

Thirty years after the identification of the disease that became known as AIDS, humanitarian organizations warn that the fight against HIV/AIDS has slowed, amid a funding shortfall and donor fatigue. In this book, Bjørn Lomborg brings together research by world-class specialist authors, a foreword by UNAIDS founding director Peter Piot and perspectives from Nobel Laureates and African civil society leaders to identify the most effective ways to tackle the pandemic across sub-Saharan Africa. There remains an alarming lack of high-quality data evaluating responses to HIV. We still know too little about what works, where and how to replicate our successes. This book offers the first comprehensive attempt by teams of authors to analyze HIV/AIDS policy choices using cost-benefit analysis, across six major topics. This approach provides a provocative fresh look at the best ways to scale up the fight against this killer epidemic.

Edited by: Bjørn Lomborg (Copenhagen Business School)
Imprint: Cambridge University Press
Country of Publication: United Kingdom
Dimensions: Height: 246mm, Width: 174mm, Spine: 18mm
Weight: 770g
ISBN: 9781107679320
ISBN 10: 110767932X
Pages: 385
Publication Date: 18 October 2012
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Foreword Peter Piot; Introduction Bjørn Lomborg; Part I. The Research: Section 1. Sexual Transmission of HIV Jere R. Behrman and Hans-Peter Kohler: 1. Alternative perspective: sexual transmission of HIV Damien de Walque; 2. Alternative perspective: sexual transmission of HIV Alan Whiteside; Section 2. Prevention of Non-sexual Transmission of HIV Lori A. Bollinger: 3. Alternative perspective: prevention of non-sexual transmission of HIV Rob Baltussen and Jan Hontelez; 4. Alternative perspective: prevention of non-sexual transmission of HIV Mira Johri; Section 3. Treatment Mead Over and Geoffrey P. Garnett: 5. Alternative perspective: treatment Robert J. Brent; 6. Alternative perspective: treatment John Stover; Section 4. Strengthening Health Systems William P. McGreevey, with Carlos Avila and Mary Punchak: 7. Alternative perspective: strengthening health systems Till Bärnighausen, David E. Bloom and Salal Humair; 8. Alternative perspective: strengthening health systems Nicoli Nattrass; Section 5. Social Policy Interventions to Enhance the HIV/AIDS Response in Sub-Saharan Africa Anna Vassall, Michelle Remme and Charlotte Watts: 9. Alternative perspective: social policy interventions to enhance the HIV/AIDS response in sub-Saharan Africa Tony Barnett; 10. Alternative perspective: social policy interventions to enhance the HIV/AIDS response in sub-Saharan Africa Harounan Kazianga; Section 6. Vaccine Research and Development Robert Hecht and Dean T. Jamison, with Jared Augenstein, Gabrielle Partridge and Kira Thorien: 11. Alternative perspective: vaccine research and development Steven Forsythe; 12. Alternative perspective: vaccine research and development Joshua A. Salomon; Part II. Ranking the Opportunities: Section 7. Findings of the Nobel Laureate Economist Expert Panel Ernest Aryeetey, Paul Collier, Edward C. Prescott, Thomas C. Schelling and Vernon L. Smith: 13. Findings from African civil society Bactrin Killingo, Nduku Kilonzo, Christiana Laniyan, Retta Menberu and Ken Odumbe; 14. Conclusion Bjørn Lomborg.

Bjorn Lomborg is Adjunct Professor at Copenhagen Business School and Director of the Copenhagen Consensus Center. He is author of best-seller The Skeptical Environmentalist (2001) and Cool It (2007) which challenged the effectiveness of standard responses to environmental challenges. He was named one of the 'top 100 global thinkers' by Foreign Policy in 2010 and 2011, one of the world's '100 most influential people' by Time and one of the '50 people who could save the planet' by The Guardian. He is a sought after speaker and opinion leader who frequently participates in debates on environmental and developmental policy choices.

Reviews for RethinkHIV: Smarter Ways to Invest in Ending HIV in Sub-Saharan Africa

'Setting priorities for how money could be spent most effectively to fight HIV AIDS in Africa is a key priority. This pioneering work shows how economic analysis can contribute to a prioritisation for spending in this vital area. It will be invaluable to those funding both research activities and healthcare programmes in Africa.' Professor Sir John Bell, President, Academy of Medical Sciences and Regius Professor of Medicine, University of Oxford Setting priorities for how money could be spent most effectively to fight HIV AIDS in Africa is a key priority. This pioneering work shows how economic analysis can contribute to a prioritisation for spending in this vital area. It will be invaluable to those funding both research activities and healthcare programmes in Africa.' - Professor Sir John Bell, President, Academy of Medical Sciences, and Regius Professor of Medicine, University of Oxford